Health
Blood Mutations Linked to Severe IBD Reveal New Treatment Path
Indiana University researchers discovered that age-related blood mutations may drive severe inflammatory bowel disease, identifying a potential new drug target for Crohn's and colitis.
Key Takeaways
- Clonal hematopoiesis blood mutations amplify IBD inflammation
- Mutant blood cells produce higher levels of inflammatory molecules
- Blocking identified pathways reduced inflammation in lab models
- Could enable precision medicine approach for treatment-resistant IBD
DE
DT Editorial AI··via medicalxpress.com
